Media ReleasesStar Combo Pharma

View All Star Combo Pharma News

Star Combo Pharma Limited announces Growth Strategy in China

ASX Announcement - Growth Strategy in China

• Opening of Sales Office in Chongqing
• Products recently approved for sale in China

Star Combo Pharma Limited (ASX:S66) is pleased to announce the official opening of its first China representative office in Chongqing China. The manager in charge of the Chongqing office has more than 20 years of experience in the marketing of vitamins.

For further information please download PDF attached:
Download this document